US Patent Issued to UNIVERSITE DE GENEVE on July 28 for "Adenosine 2A receptor modulators for use in the treatment of cancer" (French, Swiss Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,255, issued on July 28, was assigned to UNIVERSITE DE GENEVE (Geneva).

"Adenosine 2A receptor modulators for use in the treatment of cancer" was invented by Leonardo Scapozza (Grens, Switzerland), Aurelie Gouiller (Annecy, France), Margot Boujut (Bons-en-Chablais, France), Margaux Heritier (Geneva), David Pejoski (Geneva) and Thibaut De Smedt (Prevessin-Moens, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new agents useful for in the treatment of cancers, in particular by immunotherapy, as well as pharmaceutically acceptable salts thereof. In particular, this invention provides new A2AR modulators, pharmaceut...